Biolican

2 Dec 2022 | Unclassified

Biolican : To develop new technological approaches for the detection of new circulating biomarkers for the management of lung cancer. In routine clinical practice, physicians rely heavily on tumour biopsy to make a diagnosis of cancer. This tumour sample also...

LungPredict

28 Nov 2022 | Unclassified

LungPredict A collaboration in Toulouse, France, between Pierre Fabre Research Institute, the University Cancer Institute and the Cancer Research Center aims to collect and integrate data to improve and personalize lung cancer therapies. The ultimate goal of the...

MSrGB

24 Nov 2022 | Unclassified

MSrGB​: Metabolic Shift in radioresistance of GlioBlastoma Study of the involvement of metabolic shift in the radioresistance of glioblastoma stem cells: validation on blood samples and metabolic imaging of patients treated for glioblastoma in primary diagnosis...

BLOOD-REPARP

5 Oct 2022 | Unclassified

BLOOD-REPARP: Circulating biomarkers of resistance to PARP inhibitors in HER2-negative metastatic breast cancer. PARP inhibitors improve progression free survival compared to standard chemotherapy ofHER2-negativemetastaticbreast cancer (mBC) patients bearing germline...

CIRComa

30 Sep 2022 | Unclassified

CIRComa : Deciphering the role of circular RNAs in the pathogenesis and therapeutic resistance of anaplastic large cell lymphomas associated with the oncogenic tyrosine kinase ALK. Deciphering the role of circular RNAs in the pathogenesis and therapeutic resistance of...

IMAGene

28 Sep 2022 | Unclassified

IMAGene : Pancreatic Cancer Prediction in high risk individuals. Epigenomic and machine learning models to predict pancreatic cancer: development of a new algorithm to integrate clinical, omics, DNA methylation biomarkers and environmental data for early detection of...

Pin It on Pinterest